Virtual Press Office and PR Newswire: General Trade show news https://tradeshownews.vporoom.com/ Innodisk Showcases Full Qualcomm Dragonwing Edge AI Lineup at Computex 2026, Spanning Dragonwing IQ8 Through IQ10 https://tradeshownews.vporoom.com/2026-06-08-Innodisk-Showcases-Full-Qualcomm-Dragonwing-Edge-AI-Lineup-at-Computex-2026,-Spanning-Dragonwing-IQ8-Through-IQ10 Mon, 08 Jun 2026 04:22:00 -0400 https://tradeshownews.vporoom.com/2026-06-08-Innodisk-Showcases-Full-Qualcomm-Dragonwing-Edge-AI-Lineup-at-Computex-2026,-Spanning-Dragonwing-IQ8-Through-IQ10 Asia's Leading Hardware Sourcing Fair CIHS 2026 Set to Connect Global Markets in Shanghai https://tradeshownews.vporoom.com/2026-06-08-Asias-Leading-Hardware-Sourcing-Fair-CIHS-2026-Set-to-Connect-Global-Markets-in-Shanghai Mon, 08 Jun 2026 04:20:00 -0400 https://tradeshownews.vporoom.com/2026-06-08-Asias-Leading-Hardware-Sourcing-Fair-CIHS-2026-Set-to-Connect-Global-Markets-in-Shanghai Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026 https://tradeshownews.vporoom.com/2026-06-07-Novo-Nordisks-CagriSema-2-4-mg-2-4-mg-demonstrated-significant-reduction-in-HbA1c-and-weight-across-multiple-studies-in-the-REIMAGINE-program-presented-at-ADA-2026 Sun, 07 Jun 2026 17:30:00 -0400 https://tradeshownews.vporoom.com/2026-06-07-Novo-Nordisks-CagriSema-2-4-mg-2-4-mg-demonstrated-significant-reduction-in-HbA1c-and-weight-across-multiple-studies-in-the-REIMAGINE-program-presented-at-ADA-2026 AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS https://tradeshownews.vporoom.com/2026-06-07-AMGEN-PRESENTS-NEW-DATA-ACROSS-ITS-CARDIOMETABOLIC-PORTFOLIO-AT-AMERICAN-DIABETES-ASSOCIATION-86TH-SCIENTIFIC-SESSIONS Sun, 07 Jun 2026 16:45:00 -0400 https://tradeshownews.vporoom.com/2026-06-07-AMGEN-PRESENTS-NEW-DATA-ACROSS-ITS-CARDIOMETABOLIC-PORTFOLIO-AT-AMERICAN-DIABETES-ASSOCIATION-86TH-SCIENTIFIC-SESSIONS Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions https://tradeshownews.vporoom.com/2026-06-06-Novo-Nordisk-to-present-new-data-on-Wegovy-R-across-a-wide-range-of-cardiometabolic-conditions-at-the-American-Diabetes-Associations-2026-Scientific-Sessions Sat, 06 Jun 2026 13:00:00 -0400 https://tradeshownews.vporoom.com/2026-06-06-Novo-Nordisk-to-present-new-data-on-Wegovy-R-across-a-wide-range-of-cardiometabolic-conditions-at-the-American-Diabetes-Associations-2026-Scientific-Sessions